Sign in
CompletedNo phase

Serotype Distribution in Hospitalized Adult With Pneumococcal Community Acquired Pneumonia in France

Key facts

Who runs it
Institut National de la Santé Et de la Recherche Médicale, France
Where
France5 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
1,017 people enrolled
Started
9 May 2022
Ended
6 Feb 2025
Type of study
Observational
Record updated
15 May 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Adults 18 years of age or older
  • Admission to hospital for at least 24 hours
  • Suspicion of community-acquired pneumonia at admission defined as the association of: Radiologic findings consistent with pneumonia (eg, pleural effusion, increased pulmonary density due to infection and/or alveolar infiltrates [multilobar, lobar, or segmental] containing air bronchograms), AND The presence of ≥2 of the following signs or symptoms: Fever (oral temperature >38°C or tympanic temperature >38.5°C) in the 24 hours preceding admission; Hypothermia (<35.5°C measured by a healthcare provider) in the 24 hours preceding admission ; Chills or rigors ; Pleuritic chest pain ; New or worsening cough ; Sputum production ; Dyspnea (shortness of breath); Tachypnea (respiratory rate >20/min) ; Malaise ; Abnormal auscultatory findings suggestive of pneumonia (rales or evidence of pulmonary consolidation)
  • Written informed consent from the patient

Who cannot take part

  • Suspicion of tuberculosis
  • Individuals placed under judicial protection
  • Individuals who refuse the transfer of biological samples to the USA
  • Patient developing signs and symptoms of pneumonia after having been hospitalized for 48 hours or more
  • Pregnancy

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

CAP'Hospi is an observational, multicentric study in France which primary objective is to describe the proportion of Community Acquired Pneumonia due to serotypes included in PCV20 among adults hospitalized for CAP

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
15 May 2025